Aspen Pharmacare Holdings Limited APNHF
10.04 USD 0.00 (+0.00%)
Regular-session close
8.80 Day range 8.80
6.23 52-week range 10.04
- YTD
- +61.16%
- 1 year
- +61.16%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
2.34 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B+3 / 5 overall
- DCF 3
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 3
- P/E 2
- P/B 5
Valuation
P/E 23.9×
P/S 1.8×
P/B 0.8×
P/FCF 13.3×
EV/EBITDA 8.6×
EV/Sales 1.8×
FCF Yield 7.5%
Profitability
Gross Margin 40.3%
Operating Margin 15.5%
Net Margin 7.6%
ROE 3.4%
ROIC 5.6%
ROA 2.5%
Growth (YoY)
Revenue -19.3%
Operating Income 276.9%
EPS (diluted) 344.3%
Free Cash Flow 4460.5%
Financial Health
Current Ratio 2.5×
Quick Ratio 1.7×
Debt / Equity 0.2×
Net Debt / EBITDA -0.1×
Interest Coverage 3.5×
Dividends
Dividend Yield 1.5%
Payout Ratio 35.5%
Annual · latest fiscal year ends 2026-06-30
